← Leaderboards
Thomas Kislinger
Eastern Virginia Medical School
$839,251
Attributed
$2,517,754
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $827.3K · FY2016–24$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,810,827 · 2
By mechanism
U01$2,517,754 · 1
U2C$2,293,073 · 1
Top collaborators
- Paul Christopher Boutros11 shared
- Oliver John Semmes11 shared
Most similar at Eastern Virginia Medical School
Same institution · by research overlap
- Paul Christopher Boutros$16,156,127
Others in their field
Top investigators on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard A Gibbs · Baylor College Of Medicine$189,765,274
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- James Dennis Neaton · Northwestern University$166,150,536
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary L. Disis · University Of Washington$91,659,868
Research focus
HeterogeneityBiological MarkersUrineOperative Surgical ProceduresBiomarker DevelopmentDiagnosisEarly DiagnosisTumorCohortIndolentEarly Detection Research NetworkMalignant NeoplasmsMalignant Neoplasm Of ProstateDecision MakingData SetPathologistPerformanceProtein BiomarkersMass Spectrum AnalysisMolecularElementsAssay DevelopmentEarly Detection BiomarkersLiquid Substance
Grant awards (11)
Virginia-UCLA-Toronto Biomarker Characterization Center$801,603
U2C · FY2024 · CA
Virginia-UCLA-Toronto Biomarker Characterization Center$569,990
U2C · FY2023 · CA
Virginia-UCLA-Toronto Biomarker Characterization Center$257,353
U2C · FY2023 · CA
Virginia-UCLA-Toronto Biomarker Characterization Center$664,127
U2C · FY2022 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$220,035
U01 · FY2021 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$127,627
U01 · FY2021 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$433,053
U01 · FY2020 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$420,061
U01 · FY2019 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$432,349
U01 · FY2018 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$430,450
U01 · FY2017 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer$454,179
U01 · FY2016 · CA